anurajms/meta_analysis huggingface dataset:
outcomes:
Rescue high‐frequency jet ventilation versus conventional ventilation for severe pulmonary dysfunction in preterm infants
1. Chronic Lung Disease 2. Intraventricular Hemorrhage 3. Pulmonary Air Leakage 4. Hearing impairment 5. Blindness 6. Death 7. Cerebral Palsy 8. Oxygen Supplementation 9. Neurodevelopmental Delay
outcomes:
Percutaneous central venous catheters versus peripheral cannulae for delivery of parenteral nutrition in neonates
1. Nutrient Intake 2. Growth 3. Body weight 4. Developmental Delay 5. Neurodevelopmental Disorder 6. Skinfold Measurement 7. Neurodevelopmental Delay 8. Hearing Disability 9. Disability 10. Visual Disability 11. Head Circumference 12. Weight Gain 13. Height and growth measurements 14. Cerebral Palsy
outcomes:
Antimicrobial‐impregnated central venous catheters for prevention of catheter‐related bloodstream infection in newborn infants
1. Central Venous Catheter Related Bloodstream Infection
outcomes:
Standardised formal resuscitation training programmes for reducing mortality and morbidity in newborn infants
1. Cerebral Hypoxia-Ischemia 2. Competence 3. Apgar Score Low 4. Death 5. Seizure 6. Meconium Aspiration Syndrome 7. Neurodevelopmental Delay 8. Hypothermia
outcomes:
Intravenous in‐line filters for preventing morbidity and mortality in neonates
1. Bacterial Culture Positive 2. Septicemia 3. Necrotizing Enterocolitis 4. Death 5. Sepsis 6. Phlebitis 7. Fungus Culture Positive 8. Thrombus In Catheter 9. Intracardiac Thrombus
outcomes:
Regional (spinal, epidural, caudal) versus general anaesthesia in preterm infants undergoing inguinal herniorrhaphy in early infancy
1. Apnea 2. Neonatal Oxygen Desaturation 3. Intermittent Positive Pressure Breathing 4. Complication Of Anesthesia 5. Continuous Positive Airway Pressure Ventilation 6. Neurodevelopmental Delay
outcomes:
Strategies for the discontinuation of humidified high flow nasal cannula (HHFNC) in preterm infants
1. Treatment Failure 2. Noninvasive Mechanical Ventilation
outcomes:
Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants
1. Chronic Lung Disease 2. Death
outcomes:
Methods for securing endotracheal tubes in newborn infants
1. Unintended Endotracheal Extubation 2. Endotracheal Reintubation 3. Endotracheal Intubation Complication
outcomes:
Home‐ versus hospital‐based phototherapy for the treatment of non‐haemolytic jaundice in infants at more than 37 weeks' gestation
1. Light Therapy 2. Kernicterus Of Newborn 3. Serum Bilirubin level 4. Treatment Failure 5. Exchange Transfusion
outcomes:
Physical activity programs for promoting bone mineralization and growth in preterm infants
1. Bone Density 2. Bone Finding 3. Growth 4. Head Circumference 5. Fracture 6. Weight Gain 7. Height and growth measurements
outcomes:
Early light reduction for preventing retinopathy of prematurity in very low birth weight infants
1. Retinopathy Of Prematurity
outcomes:
Lung lavage for meconium aspiration syndrome in newborn infants
1. Pneumothorax 2. Pulmonary Air Leakage 3. Pneumoperitoneum 4. Pulmonary Interstitial Emphysema Syndrome 5. Length Of Stay 6. Neonatal Death 7. Oxygen Supplementation 8. Healthcare costs 9. Extracorporeal Membrane Oxygenation 10. Pneumopericardium 11. Death 12. Mediastinal Emphysema 13. Mechanical ventilation
outcomes:
Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants
1. All Cause Mortality
outcomes:
Early trophic feeding versus enteral fasting for very preterm or very low birth weight infants
1. Necrotizing Enterocolitis 2. Enteral Feeding Intolerance 3. Infant Feeding Method
outcomes:
Vasopressin and its analogues for the treatment of refractory hypotension in neonates
1. Death 2. Neurodevelopmental Delay
outcomes:
Nasal versus oral route for placing feeding tubes in preterm or low birth weight infants
1. Enteral nutrition 2. Infant Feeding Method
outcomes:
Hydralazine in infants with persistent hypoxemic respiratory failure
1. Death
outcomes:
Immunomodulators and immunosuppressants for relapsing‐remitting multiple sclerosis: a network meta‐analysis
1. Relapse 2. Disease Progression
outcomes:
Local corticosteroid injection versus placebo for carpal tunnel syndrome
1. Global Overall Symptom Scale 2. Boston Carpal Tunnel Questionnaire 3. Quality of Life 4. Adverse Event 5. Disability of the Arm, Shoulder and Hand 6. Carpal Tunnel Syndrome
outcomes:
Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis
1. Adverse Event 2. Clinical Improvement
outcomes:
Topical clonidine for neuropathic pain in adults
1. Patient Global Impression of Improvement 2. Adverse Event 3. Pain Relief 4. Patient-Reported Outcome
outcomes:
Ocrelizumab for multiple sclerosis
1. Multiple Sclerosis 2. Disability 3. Relapse 4. Serious Adverse Event 5. Disability Rating Scale 6. Treatment discontinued 7. Adverse Event
outcomes:
Immunoglobulin for multifocal motor neuropathy
1. Disability 2. Motor Nerve Conduction Pattern 3. Muscle Strength
outcomes:
Siponimod for multiple sclerosis
1. Disability 2. Relapse 3. Adverse Event
outcomes:
Rituximab for people with multiple sclerosis
1. Disability 2. Infection 3. Relapse 4. Serious Adverse Event 5. Quality of Life 6. Death 7. Cancer
outcomes:
Memory rehabilitation for people with multiple sclerosis
1. Activities of Daily Living 2. Rivermead Behavioral Memory Test 3. Everyday Memory Questionnaire 4. Multiple Sclerosis Quality of Life-54 5. Quality of Life 6. Symbol Digit Modalities Test 7. California Verbal Learning Test 8. Memory Finding 9. Brief Visuospatial Memory Test
outcomes:
Interventions for promoting physical activity in people with neuromuscular disease
1. Walking 2. SF-36 Physical Function Score 3. Physical Activity Level 4. Quality of Life 5. SF36-MCS
outcomes:
GLP‐1 receptor agonists for Parkinson's disease
1. Serious Adverse Event 2. Weight Loss 3. Motor impairment 4. Adverse Event 5. Health-Related Quality of Life 6. Unified Parkinson's Disease Rating Scale (MDS-UPDRS) subscale Part III (Fahn 1987)
outcomes:
Anti‐epidermal growth factor receptor therapy for glioblastoma in adults
1. Death 2. Adverse Event
outcomes:
Cell‐based therapies for amyotrophic lateral sclerosis/motor neuron disease
1. Assessment Using Assessment Scale 2. Forced Vital Capacity 3. Treatment Withdrawal 4. Injection Site Reaction 5. Death 6. Muscle Strength 7. Thromboembolic Event 8. Cardiovascular Morbidity 9. Revised Amyotrophic Lateral Sclerosis Functional Rating Scale
outcomes:
Interventions for preventing falls in people with multiple sclerosis
1. Falls 2. Adverse Event
outcomes:
Indomethacin for intracranial hypertension secondary to severe traumatic brain injury in adults
1. Finding Of Intracranial Pressure
outcomes:
Exercise therapy for chronic fatigue syndrome
1. Pain 2. Serious Adverse Event 3. Sleep Finding 4. Quality of Life 5. Fatigue 6. Depression 7. General Physical Finding 8. Adverse Event 9. Pain Intensity
outcomes:
Psychological therapies for the prevention of migraine in adults
1. Adverse Event
outcomes:
Mixed exercise training for adults with fibromyalgia
1. Disability 2. Withdrawn From Research Study 3. Pain 4. Serious Adverse Event 5. Pain Scale 6. Fatigue 7. Stiffness 8. Functional ability 9. Adverse Event 10. Health-Related Quality of Life 11. Pain Intensity
outcomes:
Non‐pharmacological interventions for chronic pain in multiple sclerosis
1. Pain Relief
outcomes:
Information provision for people with multiple sclerosis
1. Shared Decision Making 2. Patient knowledge 3. Quality of Life 4. Adverse Event
outcomes:
Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia
1. Treatment Withdrawal 2. Serious Adverse Event 3. Pain Relief
outcomes:
Combination pharmacotherapy for the treatment of fibromyalgia in adults
1. Treatment Withdrawal 2. Serious Adverse Event 3. Adverse Event 4. Pain Relief
outcomes:
Absorbable versus non‐absorbable sutures for skin closure after carpal tunnel decompression surgery
1. Postoperative Pain 2. Hand Function Disability 3. Wound Inflammation 4. Scarring
outcomes:
Drug management for acute tonic‐clonic convulsions including convulsive status epilepticus in children
1. Cardiac Arrhythmia 2. Extravasation 3. Convulsive Status Epilepticus 4. Respiratory Arrest 5. Low Blood Pressure 6. Seizure 7. Decreased Respiratory Function
outcomes:
Botulinum toxin for motor and phonic tics in Tourette's syndrome
1. Tic Symptom Self-Report 2. Gilles de la Tourette Syndrome-Quality of Life Scale 3. Tourette Syndrome Severity Scale 4. Tic Count 5. Premonitory sensation 6. Tic rate video review 7. Yale Global Tic Severity Scale 8. Tic count video review 9. Adverse Event 10. Immunoresistance 11. Tic
outcomes:
Treatment of fatigue in amyotrophic lateral sclerosis/motor neuron disease
1. Fatigue
outcomes:
Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy
1. Cushingoid Facies 2. Disability 3. Insomnia 4. Remission 5. Inflammatory Neuropathy
outcomes:
alemtuzumab versus interferon beta 1a for relapsing‐remitting multiple sclerosis
1. Relapse 2. Serious Adverse Event 3. Disease Progression 4. Adverse Event 5. Expanded Disability Status Scale
outcomes:
Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease
1. Overall Survival 2. Amyotrophic Lateral Sclerosis Functional Rating Scale 3. Survival 4. Revised Amyotrophic Lateral Sclerosis Functional Rating Scale 5. Health Assessment Questionnaire
outcomes:
Whole body vibration exercise training for fibromyalgia
1. Disability 2. Withdrawn From Research Study 3. Pain 4. Fatigue 5. Stiffness 6. Functional ability 7. Adverse Event 8. Health-Related Quality of Life
outcomes:
Zonisamide for essential tremor
1. Withdrawn From Research Study 2. Functional ability 3. Adverse Event
outcomes:
Immunotherapy for diabetic amyotrophy
1. Therapy Outcome Measure 2. Neurological Impairment
outcomes:
Aerobic exercise training for adults with fibromyalgia
1. Disability 2. Withdrawn From Research Study 3. Pain 4. Fatigue 5. Stiffness 6. Functional ability 7. Adverse Event 8. Health-Related Quality of Life
outcomes:
Drug therapy for chronic idiopathic axonal polyneuropathy
1. Disability
outcomes:
Tramadol for neuropathic pain in adults
1. Treatment Withdrawal 2. Serious Adverse Event 3. Death 4. Adverse Event 5. Pain Relief
outcomes:
Gabapentin for chronic neuropathic pain in adults
1. Serious Adverse Event 2. Death 3. Withdrawal Due To Adverse Events 4. Patient's Global Evaluation 5. Pain Intensity
outcomes:
Antiepileptic drugs for the treatment of infants with severe myoclonic epilepsy
1. Seizure
outcomes:
Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy
1. Disability 2. Serious Adverse Event 3. Medication Dose Changed
outcomes:
Topiramate for essential tremor
1. Withdrawn From Research Study 2. Tremor Rating Scale (TRS) 3. Functional ability 4. Adverse Event
outcomes:
Benzodiazepines for restless legs syndrome
1. Clinical Improvement
outcomes:
Plasma exchange for Guillain‐Barré syndrome
1. Infection 2. Relapse 3. Finding Related To Ability To Initiate Walking 4. Dependence On Ventilator 5. Death 6. Ability to walk 7. Muscle Strength
outcomes:
Propofol versus thiopental sodium for the treatment of refractory status epilepticus
1. Death 2. Seizure 3. Intensive Care
outcomes:
Interventions to prevent and treat corticosteroid‐induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy
1. Visual Analog Pain Scale 2. Bone Density 3. Bone Pain 4. Quality of Life 5. Dual Energy X-ray Photon Absorptiometry 6. Fracture 7. Pathological Fracture Of Vertebra
outcomes:
Aspirin for acute treatment of episodic tension‐type headache in adults
1. Serious Adverse Event 2. Adverse Event 3. Rescue Medication 4. Pain Relief 5. Patient's Global Evaluation
outcomes:
Gamma aminobutyric acid (GABA) modulators for amyotrophic lateral sclerosis/motor neuron disease
1. Assessment Using Assessment Scale 2. Forced Vital Capacity 3. Death 4. Amyotrophic Lateral Sclerosis Functional Rating Scale 5. Muscle Strength 6. Survival 7. Revised Amyotrophic Lateral Sclerosis Functional Rating Scale
outcomes:
Progesterone for acute traumatic brain injury
1. Disability 2. Blood pressure measurement 3. Finding Of Intracranial Pressure 4. Death 5. Temperature 6. Adverse Event
outcomes:
Immediate‐release versus controlled‐release carbamazepine in the treatment of epilepsy
1. Seizure
outcomes:
Antibiotics for the neurological complications of Lyme disease
1. Disability 2. Neurological Morbidity 3. Pleocytosis 4. Clinical Resolution
outcomes:
Pregabalin for essential tremor
1. Withdrawn From Research Study 2. Adverse Event 3. Functional ability
outcomes:
Immunotherapy for IgM anti‐myelin‐associated glycoprotein paraprotein‐associated peripheral neuropathies
1. Disability 2. Assessment Using Assessment Scale 3. 10 Meter Walk Test 4. Impairment 5. Neuropathy Impairment Scale 6. Monoclonal Paraproteinemia 7. Rankin Disability Scale
outcomes:
External drains versus no drains after burr‐hole evacuation for the treatment of chronic subdural haematoma in adults
1. Chronic Intracranial Subdural Hematoma 2. Death 3. Complication 4. Functional ability
outcomes:
Pharmacological treatments for Friedreich ataxia
1. Assessment Using Assessment Scale 2. Magnetic Resonance Imaging Of Cardiac Ventricles 3. Scale for the Assessment and Rating of Ataxia 4. Serious Adverse Event 5. Interventricular Cardiac Septal Hypertrophy 6. Left Ventricular Mass 7. Myocardial Finding 8. Left Ventricular Ejection Fraction 9. Friedreich Ataxia Rating Scale 10. Echocardiography For Determining Ventricular Contraction 11. Echocardiography For Determining Interventricular Septal Thickness 12. International Cooperative Ataxia Rating Scale
outcomes:
Corticosteroids for Bell's palsy (idiopathic facial paralysis)
1. Autonomic Neuropathy 2. Inadequate Clinical Response To Medication 3. Facial appearance 4. Synkinesis Of Face 5. Crocodile Tears Syndrome 6. Facial Spasm
outcomes:
Cannabinoids for fibromyalgia
1. Serious Adverse Event 2. Pain 3. Withdrawal Due To Adverse Events 4. Pain Relief 5. Patient's Global Evaluation
outcomes:
Opioids for restless legs syndrome
1. Restless Legs Syndrome Quality of Life Questionnaire 2. Quality of Life 3. Adverse Event 4. Clinical Improvement 5. Patient-Reported Outcome
outcomes:
Paracetamol (acetaminophen) for acute treatment of episodic tension‐type headache in adults
1. Pain Intensity Rating Scale 2. Serious Adverse Event 3. Adverse Event 4. Rescue Medication 5. Time-to-Event 6. Pain Relief
outcomes:
Antipsychotics for fibromyalgia in adults
1. Serious Adverse Event 2. Depression 3. Sleep Problem 4. Withdrawal Due To Adverse Events 5. Weight Gain 6. Pain Relief 7. Patient's Global Evaluation
outcomes:
Pharmacological treatment for Kleine‐Levin syndrome
1. Kleine-levin Syndrome
outcomes:
Corticosteroids for the treatment of Duchenne muscular dystrophy
1. Cushingoid Facies 2. Medical Research Council Motor Power Scale 3. Forced Vital Capacity 4. Cataract 5. Brooke Scale 6. 10 Meter Walk Test 7. Assessment Of Ability To Walk 8. Paediatric Quality of Life Inventory 9. Ability to walk 10. Abnormal Behavior 11. Infection 12. Hyperglycemia 13. Pathological Fracture 14. Assessment Using Functional Assessment Measure 15. Quality of Life 16. Death 17. Height 18. Weight Gain 19. Muscle Strength 20. Hypertensive disorder
outcomes:
Antiepileptic drugs for the primary and secondary prevention of seizures after intracranial venous thrombosis
1. Seizure
outcomes:
Sumatriptan plus naproxen for the treatment of acute migraine attacks in adults
1. Serious Adverse Event 2. Adverse Event 3. Time-to-Event 4. Pain Relief
outcomes:
Drugs for the acute treatment of migraine in children and adolescents
1. Adverse Event 2. Time-to-Event 3. Pain Relief
outcomes:
Fingolimod for relapsing‐remitting multiple sclerosis
1. Disability 2. Relapse 3. Adverse Event
outcomes:
Posture and fluids for preventing post‐dural puncture headache
1. Headache 2. Post Dural Puncture Headache 3. Time-to-Event
outcomes:
Interventions for psychotic symptoms concomitant with epilepsy
1. Costs and Cost Analysis 2. Quality of Life 3. Hospitalization
outcomes:
Alprazolam for essential tremor
1. Tremor Rating Scale (TRS) 2. Quality of Life 3. Withdrawal Due To Adverse Events 4. Tremor Severity 5. Investigator Global Assessment
outcomes:
Vigabatrin versus carbamazepine monotherapy for epilepsy
1. Treatment Withdrawal
outcomes:
Routine intracranial pressure monitoring in acute coma
1. Disability - Severe 2. Death
outcomes:
Psychological therapies for the management of chronic neuropathic pain in adults
1. Disability 2. Withdrawn From Research Study 3. Pain 4. Quality of Life 5. Depression 6. Anxiety 7. Adverse Event 8. Patient-Reported Outcome
outcomes:
Sodium channel blockers for neuroprotection in multiple sclerosis
1. Relapse 2. Disease Progression 3. Adverse Event
outcomes:
Milnacipran for pain in fibromyalgia in adults
1. Serious Adverse Event 2. Patient Global Impression of Improvement 3. Adverse Event 4. Pain Relief
outcomes:
Interventions for fatigue in Parkinson's disease
1. Headache 2. Tachycardia 3. Impulse Control Disorder 4. Quality of Life 5. Orthostatic Hypotension 6. Anxiety 7. Nausea 8. Fatigue Severity Scale 9. Hypertensive disorder
outcomes:
Oral nonsteroidal anti‐inflammatory drugs for neuropathic pain
1. Pain Relief 2. Patient-Reported Outcome
outcomes:
Surgery for scoliosis in Duchenne muscular dystrophy
1. Assessment Using Assessment Scale 2. Pseudoarthrosis 3. Scoliosis Survey X-ray 4. Pneumonia 5. Surgical complication 6. Functional Independence Measure 7. Loosening Of Internal Fixation Device 8. Respiratory Function 9. Survival 10. Wound Dehiscence 11. Barthel Index 12. Disability 13. Serious Adverse Event 14. Revision 15. Short Form Health Survey - 36 16. Death 17. Wound Infection
outcomes:
Buprenorphine for neuropathic pain in adults
1. Patient Global Impression of Improvement 2. Pain Relief 3. Patient-Reported Outcome
outcomes:
Exercise therapy for fatigue in multiple sclerosis
1. Muscle Power 2. Fatigue
outcomes:
Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy
1. Disability 2. Serious Adverse Event 3. Modified Rankin Scale 4. Impairment 5. Neuropathy Impairment Scale 6. Nerve Conduction Studies
outcomes:
Venlafaxine for neuropathic pain in adults
1. Patient Global Impression of Improvement 2. Pain Relief
outcomes:
Pharmacological treatments for preventing epilepsy following traumatic head injury
1. Death 2. Seizure 3. Late Seizure
outcomes:
Ibuprofen for acute treatment of episodic tension‐type headache in adults
1. Serious Adverse Event 2. Adverse Event 3. Rescue Medication 4. Time-to-Event 5. Pain Relief 6. Patient's Global Evaluation
outcomes:
Neuropsychological and psychological interventions for people with newly diagnosed epilepsy
1. Seizure 2. Adverse Event
outcomes:
Drug therapy for treating post‐dural puncture headache
1. Post Dural Puncture Headache
outcomes:
Amitriptyline for neuropathic pain in adults
1. Pain Relief 2. Patient's Global Evaluation 3. Patient-Reported Outcome
outcomes:
Milnacipran for neuropathic pain in adults
1. Patient Global Impression of Improvement 2. Pain Relief
outcomes:
Selective serotonin reuptake inhibitors for fibromyalgia syndrome
1. Serious Adverse Event 2. Pain 3. Fibromyalgia 4. Fatigue 5. Depression 6. Sleep Problem 7. Withdrawal Due To Adverse Events
outcomes:
Selective serotonin reuptake inhibitors (SSRIs) and serotonin‐norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension‐type headache in adults
1. Pain Intensity Rating Scale 2. Headache 3. Duration of Symptom 4. Pain Relief By Medication 5. Frequency of symptom 6. Quality of Life 7. Withdrawal Due To Adverse Events
outcomes:
Dimethyl fumarate for multiple sclerosis
1. Relapse 2. Disease Progression 3. Adverse Event
outcomes:
Telerehabilitation for persons with multiple sclerosis
1. Disability 2. Impairment 3. Pain And Sensation Symptom Findings 4. Quality of Life 5. Depression 6. Not reported 7. Functional ability 8. Adverse Event
outcomes:
Selective serotonin reuptake inhibitors (SSRIs) and serotonin‐norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults
1. Pain Intensity Rating Scale 2. Duration of Symptom 3. Pain Relief By Medication 4. Frequency of symptom 5. Migraine 6. Quality of Life 7. Withdrawal Due To Adverse Events
outcomes:
Treatment for IgG and IgA paraproteinaemic neuropathy
1. Disability 2. Neuropathy Impairment Scale 3. Inflammatory Neuropathy Cause and Treatment Disability Scale 4. Adverse Event 5. Rasch-built Overall Disability Scale
outcomes:
Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy
1. Assessment Using Assessment Scale 2. Serious Adverse Event 3. Rankin Disability Scale
outcomes:
Physical rehabilitation for critical illness myopathy and neuropathy
1. Functional Assessment Measure 2. Functional Independence Measure 3. Finding Related To Ability To Perform Activities Of Everyday Life 4. Barthel Index
outcomes:
Early versus late antiepileptic drug withdrawal for people with epilepsy in remission
1. Seizure
outcomes:
Interventions for fatigue in peripheral neuropathy
1. SF-36 Physical Function Score 2. Serious Adverse Event 3. Fatigue 4. Health-Related Quality of Life
outcomes:
Non‐pharmacological interventions for chronic pain in people with spinal cord injury
1. Pain 2. Pain Relief 3. Pain Intensity
outcomes:
Aquatic exercise training for fibromyalgia
1. Treatment Withdrawal 2. Pain 3. Cardiorespiratory Monitoring 4. Stiffness 5. Adverse Event 6. Muscle Strength 7. Functional ability
outcomes:
Pharmacotherapy for sleep bruxism
1. Sleep-related Bruxism
outcomes:
Acetylcholinesterase inhibitor treatment for myasthenia gravis
1. Muscle 2. Clinical Improvement
outcomes:
Intravenous immunoglobulin for Guillain‐Barré syndrome
1. Headache 2. Drug-induced Autonomic Dysfunction 3. Hughes Disability Scale 4. Fluctuation 5. Ability to walk 6. Hemorrhage 7. Artificial Ventilation Finding 8. Disability 9. Renal Failure 10. Infection 11. Cardiac Arrhythmia 12. Abnormal Liver Function 13. Death 14. Skin Rash 15. Hypertensive disorder
outcomes:
Anticonvulsant therapy for status epilepticus
1. Ventilator 2. Adverse Drug Reaction 3. Hospital discharge 4. Status Epilepticus 5. Death 6. Sequelae Of Neurological Disorders 7. Antiepileptics 8. General Anesthetics 9. Seizure
outcomes:
Comparison of antiepileptic drugs, no treatment, or placebo for children with benign epilepsy with centro temporal spikes
1. Cognitive function 2. Seizure 3. Adverse Event 4. Sleepiness 5. Skin Rash
outcomes:
Physiotherapy for Parkinson's disease: a comparison of techniques
1. Disability 2. Costs and Cost Analysis 3. Finding Of Gait 4. Fall 5. Adverse Event 6. Walking Distance
outcomes:
Zolmitriptan for acute migraine attacks in adults
1. Serious Adverse Event 2. No Present Pain 3. Adverse Event 4. Time-to-Event 5. Pain Relief
outcomes:
Carbamazepine for chronic neuropathic pain and fibromyalgia in adults
1. Pain Sensation Reduced 2. Pain 3. Serious Adverse Event 4. Death 5. Patient Global Impression of Change 6. Withdrawal Due To Adverse Events 7. Adverse Event 8. Pain Relief 9. Patient-Reported Outcome
outcomes:
Mycophenolate mofetil for relapsing‐remitting multiple sclerosis
1. Relapse 2. Disease Progression 3. Adverse Event 4. Expanded Disability Status Scale
outcomes:
Antiviral treatment for preventing postherpetic neuralgia
1. Postherpetic Neuralgia 2. Adverse Event
outcomes:
Interventions for preventing critical illness polyneuropathy and critical illness myopathy
1. Intensive Care
outcomes:
Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia
1. Pain Intensity Rating Scale 2. Withdrawal Due To Adverse Events 3. Clinical Improvement 4. Patient-Reported Outcome
outcomes:
Immunotherapy for idiopathic lumbosacral plexopathy
1. Disability 2. Overall Disability Status Scale
outcomes:
Mechanical insufflation‐exsufflation for people with neuromuscular disorders
1. Death
outcomes:
Passive movements for the treatment and prevention of contractures
1. Pain 2. Heterotopic Ossification 3. Spasticity 4. Rupture Of Muscle 5. Autonomic Dysreflexia 6. Fracture 7. Dislocation Of Joint
outcomes:
Daclizumab for relapsing remitting multiple sclerosis
1. Adverse Event 2. Expanded Disability Status Scale
outcomes:
Pharmacological treatment for memory disorder in multiple sclerosis
1. Buschke Selective Reminding Test 2. Abnormal dreams 3. Diarrhea 4. Nausea 5. Paced Auditory Stimulation Test 6. Memory performance 7. Symbol Digit Modalities Test 8. Adverse Event
outcomes:
Rituximab for relapsing‐remitting multiple sclerosis
1. Relapse 2. Serious Adverse Event 3. Disease Progression 4. Adverse Event
outcomes:
Non‐antiepileptic drugs for trigeminal neuralgia
1. Short Form Health Survey - 36 2. Quality of Life 3. Adverse Event 4. Trigeminal Neuralgia 5. Pain Relief
outcomes:
Lamotrigine for chronic neuropathic pain and fibromyalgia in adults
1. Rash 2. Serious Adverse Event 3. Pain 4. Death 5. Patient Global Impression of Change 6. Adverse Event 7. Pain Relief 8. Pain Intensity 9. Patient-Reported Outcome
outcomes:
Naproxen with or without an antiemetic for acute migraine headaches in adults
1. Headache 2. Serious Adverse Event 3. Adverse Event 4. Pain Relief
outcomes:
Thymectomy for non‐thymomatous myasthenia gravis
1. Clinical Improvement
outcomes:
Physiotherapy versus placebo or no intervention in Parkinson's disease
1. Costs and Cost Analysis 2. Gait 3. Short Form Health Survey - 36 4. Webster Score 5. Parkinson's Disease Quality of Life Questionnaire (PDQL) (de Boer 1996) 6. Hoehn And Yahr Scale 7. Parkinsons Disease Questionnaire (PDQ-39) (Peto 1995) 8. Columbia University Rating Scale 9. Walking Speed 10. Functional ability 11. Adverse Event 12. Unified Parkinson's Disease Rating Scale
outcomes:
Botulinum toxin for masseter hypertrophy
1. Patient Satisfaction 2. Patient-Reported Outcome
outcomes:
Topiramate for neuropathic pain and fibromyalgia in adults
1. Serious Adverse Event 2. Visual Analog Scale 3. Death 4. Withdrawal Due To Adverse Events 5. Patient Global Impression of Improvement 6. Pain Relief 7. Patient-Reported Outcome
outcomes:
Nonoperative treatment for lumbar spinal stenosis with neurogenic claudication
1. Disability 2. Quality of Life 3. Ability to walk 4. Patient Global Impression of Improvement 5. Functional ability 6. Clinical Improvement 7. Pain Intensity
outcomes:
Triptans for acute cluster headache
1. Headache 2. Serious Adverse Event 3. Adverse Event 4. Pain Relief
outcomes:
Antiepileptic drugs for the primary and secondary prevention of seizures after subarachnoid haemorrhage
1. Stroke 2. Quality of Life
outcomes:
Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease
1. Short Form Health Survey - 36 2. Amyotrophic Lateral Sclerosis Functional Rating Scale 3. Manual Muscle Testing Score 4. Adverse Event 5. Functional ability 6. Fatigue Severity Scale
outcomes:
Mitoxantrone for multiple sclerosis
1. Disease Progression 2. Adverse Event
outcomes:
Paracetamol (acetaminophen) with or without an antiemetic for acute migraine headaches in adults
1. Headache 2. Pain 3. Referral To Accident And Emergency Service
outcomes:
Aspirin with or without an antiemetic for acute migraine headaches in adults
1. Serious Adverse Event 2. No Present Pain 3. Adverse Event 4. Time-to-Event 5. Pain Relief
outcomes:
Diclofenac with or without an antiemetic for acute migraine headaches in adults
1. Serious Adverse Event 2. Adverse Event 3. No Present Pain 4. Time-to-Event 5. Pain Relief
outcomes:
Ibuprofen with or without an antiemetic for acute migraine headaches in adults
1. Serious Adverse Event 2. Adverse Event 3. No Present Pain 4. Time-to-Event 5. Pain Relief
outcomes:
Drug therapy for preventing post‐dural puncture headache
1. Post Dural Puncture Headache
outcomes:
Intravenous immunoglobulin for myasthenia gravis
1. Assessment Using Functional Assessment Measure 2. Fatigue 3. Withdrawal Due To Adverse Events 4. Muscle Strength 5. Fatigue Severity Scale 6. Clinical Improvement
outcomes:
Cognitive behavioural therapy (CBT) with and without exercise to reduce fear of falling in older people living in the community
1. Falls 2. Fear-related avoidance of activities 3. Fear Of Falling 4. Frequency Of Falls 5. Assessment Using Activities-specific Balance Confidence Scale 6. Depressive symptoms 7. Anxiety 8. Fall 9. Assessment Using Short Falls Efficacy - International Scale
outcomes:
Hypothermia for neuroprotection in adults after cardiac arrest
1. Pneumonia 2. Hypokalemia 3. Neurological Finding 4. Survival 5. Clinical Improvement
outcomes:
Environmental interventions for preventing falls in older people living in the community
1. Falls
outcomes:
Systemic corticosteroids for radicular and non‐radicular low back pain
1. Oswestry Disability Index 2. Hyperglycemia 3. Serious Adverse Event 4. Pain 5. Surgery 6. Functional ability
outcomes:
Peripheral nerve blocks for hip fractures in adults
1. Hip Joint Painful On Movement 2. All Cause Mortality 3. Myocardial Infarction 4. Healthcare costs 5. Pneumonia 6. Acute Confusion 7. Therapeutic mobilization
outcomes:
Shoulder replacement surgery for osteoarthritis and rotator cuff tear arthropathy
1. Visual Analog Pain Scale 2. Repeat surgery 3. Functional ability 4. Adverse Event 5. Disability 6. Serious Adverse Event 7. Pain 8. Revision 9. Western Ontario And Mcmaster Universities Osteoarthritis Index 10. Treatment Success 11. Treatment Failure 12. Quality of Life 13. Subjective Global Assessment
outcomes:
Shock wave therapy for rotator cuff disease with or without calcification
1. Disability 2. Visual Analog Pain Scale 3. Treatment Withdrawal 4. Pain 5. Pain Scale 6. Treatment Success 7. Quality of Life 8. Withdrawal Due To Adverse Events 9. Functional ability 10. Adverse Event 11. Pain Relief 12. Patient-Reported Outcome
outcomes:
Prophylactic antibiotics for penetrating abdominal trauma
1. Sepsis
outcomes:
Pregabalin for neuropathic pain in adults
1. Dizziness 2. Pain Onset At Rest 3. Treatment Withdrawal 4. Serious Adverse Event 5. Withdrawal Due To Adverse Events 6. Sleepiness 7. Adverse Event 8. Pain Relief 9. Patient's Global Evaluation 10. Pain Upon Movement
outcomes:
Multifactorial and multiple component interventions for preventing falls in older people living in the community
1. Falls 2. Non-urgent Hospital Admission 3. Quality of Life 4. Fracture 5. Emergency Hospital Admission
outcomes:
One‐incision versus two‐incision techniques for arthroscopically assisted anterior cruciate ligament reconstruction in adults
1. Treatment Failure 2. Physical Activity Level 3. Quality of Life
outcomes:
Neuromuscular electrical stimulation (NMES) for patellofemoral pain syndrome
1. Knee Pain 2. Adverse Event
outcomes:
Antiseptics for burns
1. Wound Healing 2. Adverse Event 3. Wound Infection
outcomes:
Desmopressin use for minimising perioperative blood transfusion
1. Blood Transfusion 2. Death 3. Haemorrhage 4. Thrombosis
outcomes:
Injected corticosteroids for treating plantar heel pain in adults
1. Serious Adverse Event 2. Treatment Failure 3. Heel Pain 4. Functional ability
outcomes:
Single dose oral ketoprofen or dexketoprofen for acute postoperative pain in adults
1. Serious Adverse Event 2. Adverse Event 3. Rescue Medication 4. Pain Relief
outcomes:
Capnography versus standard monitoring for emergency department procedural sedation and analgesia
1. Vomiting 2. Aspiration 3. Desaturation Of Blood 4. Low Blood Pressure 5. Time-to-Event 6. Oxygen Supplementation 7. Clinical Improvement
outcomes:
Interventions for treating simple bone cysts in the long bones of children
1. Fracture Malunion 2. Infection 3. Bone Cyst 4. Pathological Fracture 5. Pain 6. Pain Scale 7. Treatment Failure 8. Adverse Event 9. Functional ability
outcomes:
Liposomal bupivacaine infiltration at the surgical site for the management of postoperative pain
1. Pain Intensity Rating Scale 2. Serious Adverse Event 3. Opioids 4. Adverse Event 5. Time-to-Event
outcomes:
School‐based education programmes for the prevention of unintentional injuries in children and young people
1. Traumatic Injury
outcomes:
Pharmacologic interventions for treating phantom limb pain
1. Intensity Change
outcomes:
Antifibrinolytic agents for reducing blood loss in scoliosis surgery in children
1. Blood Transfusion 2. Allogeneic Blood Bag 3. Exsanguination
outcomes:
Liposomal bupivacaine peripheral nerve block for the management of postoperative pain
1. Serious Adverse Event 2. Visual Analog Scale 3. Pain Relief 4. Pain Intensity 5. Patient-Reported Outcome
outcomes:
Technological aids for the rehabilitation of memory and executive functioning in children and adolescents with acquired brain injury
1. Academic Underachievement 2. Intellectual Functioning Disability 3. Psychological Finding 4. Quality of Life 5. Psychosocial functioning 6. Adverse Event 7. Memory Finding
outcomes:
Single dose intravenous paracetamol or intravenous propacetamol for postoperative pain
1. Pain Relief 2. Pain Intensity
outcomes:
Single dose intra‐articular morphine for pain control after knee arthroscopy
1. Visual Analog Pain Scale 2. Postoperative Pain 3. Analgesics 4. Adverse Event 5. Rescue Medication 6. Time-to-Event
outcomes:
Vapocoolants (cold spray) for pain treatment during intravenous cannulation
1. Pain 2. Treatment Success 3. Adverse Event
outcomes:
Single dose dipyrone (metamizole) for acute postoperative pain in adults
1. Serious Adverse Event 2. Adverse Event 3. Time-to-Event 4. Pain Relief 5. Postoperative Analgesia
outcomes:
Interventions for treating ankle fractures in children
1. Infection 2. Pain 3. Ankle Joint Deformity 4. Surgery 5. Physical Activity Level 6. Soft Tissue Injury 7. Patient Satisfaction 8. Outcome Measure
outcomes:
Perioperative fluid volume optimization following proximal femoral fracture
1. All Cause Mortality 2. Mobility function 3. Neurological Finding 4. Length Of Stay 5. Medically Fit For Discharge 6. Adverse Event 7. Time-to-Event
outcomes:
Anaesthesia for hip fracture surgery in adults
1. Delirium 2. Pneumonia 3. Myocardial Infarction 4. Stroke 5. Return To Family Home 6. Death 7. Deep Venous Thrombosis
outcomes:
Surgical versus non‐surgical treatment for lumbar spinal stenosis
1. Disability 2. Pain 3. Pain Scale 4. Functional ability 5. Health-Related Quality of Life 6. Walking Distance 7. Pain Intensity
outcomes:
Helicopter emergency medical services for adults with major trauma
1. Disability 2. Hospital discharge 3. Quality of Life 4. Death 5. Adverse Event
outcomes:
Knee orthoses for treating patellofemoral pain syndrome
1. Pain 2. Quality of Life 3. Functional ability 4. Adverse Event 5. Patient Satisfaction
outcomes:
Manipulation and mobilisation for neck pain contrasted against an inactive control or another active treatment
1. Disability 2. Pain 3. Quality of Life 4. Global Assessment 5. Functional ability 6. Pain Relief 7. Patient Satisfaction
outcomes:
Whole‐body cryotherapy (extreme cold air exposure) for preventing and treating muscle soreness after exercise in adults
1. Pain 2. Pain Scale 3. General well-being 4. Tiredness 5. Muscular Pain 6. Adverse Event
outcomes:
Hemodialysis for lithium poisoning
1. Neurological Examination Abnormal
outcomes:
Emergency ultrasound‐based algorithms for diagnosing blunt abdominal trauma
1. All Cause Mortality
outcomes:
Surgical versus nonsurgical interventions for flail chest
1. Death
outcomes:
Steroidal contraceptives and bone fractures in women: evidence from observational studies
1. Fracture
outcomes:
Single dose oral diclofenac for acute postoperative pain in adults
1. Serious Adverse Event 2. Pain Relief
outcomes:
Prothrombin complex concentrate for reversal of vitamin K antagonist treatment in bleeding and non‐bleeding patients
1. Blood Transfusion 2. Death 3. Complication
outcomes:
Patient controlled opioid analgesia versus non‐patient controlled opioid analgesia for postoperative pain
1. Pain Intensity 2. Supervised Consumption Of Medication
outcomes:
Injection therapies for Achilles tendinopathy
1. Serious Adverse Event 2. Pain 3. Functional ability
outcomes:
Antifibrinolytic drugs for acute traumatic injury
1. Intracerebral Hemorrhage 2. Stroke 3. Myocardial Infarction 4. Blood Transfusion 5. Surgery 6. Death 7. Pulmonary Embolism 8. Deep Venous Thrombosis 9. Brain Lesion
outcomes:
Sweet tasting solutions for reduction of needle‐related procedural pain in children aged one to 16 years
1. Duration of Symptom 2. Crying duration 3. Pain Intensity
outcomes:
Corticosteroids for the management of cancer‐related pain in adults
1. Pain Relief 2. Pain Intensity 3. Patient-Reported Outcome
outcomes:
Surgical versus non‐surgical interventions in people with adolescent idiopathic scoliosis
1. Disability 2. Disease Progression 3. Psychological Finding 4. Trunk Position Finding 5. Quality of Life 6. Appearance 7. Adolescent Idiopathic Scoliosis 8. Back pain
outcomes:
Red blood cell transfusion for people undergoing hip fracture surgery
1. Serious Adverse Event 2. Postoperative Morbidity
outcomes:
Surgical interventions for treating distal tibial metaphyseal fractures in adults
1. Pain 2. Functional ability
outcomes:
Tramadol for postoperative pain treatment in children
1. Postoperative Pain 2. Analgesia 3. Postoperative Vomiting 4. Postoperative Nausea
outcomes:
Effectiveness of posterior decompression techniques compared with conventional laminectomy for lumbar stenosis
1. Disability 2. Visual Analog Pain Scale 3. Leg Pain 4. Postoperative Morbidity 5. Complication 6. Back pain 7. Clinical Improvement 8. Patient-Reported Outcome
outcomes:
As required versus fixed schedule analgesic administration for postoperative pain in children
1. Adverse Event 2. Pain Relief 3. Pain Intensity
outcomes:
Single dose oral ibuprofen plus codeine for acute postoperative pain in adults
1. Serious Adverse Event 2. Death 3. Adverse Event 4. Pain Relief
outcomes:
Cell salvage in emergency trauma surgery
1. Death
outcomes:
Exercise for treating patellofemoral pain syndrome
1. Knee Pain 2. Functional ability
outcomes:
Single induction dose of etomidate versus other induction agents for endotracheal intubation in critically ill patients
1. Serum Cortisol 2. All Cause Mortality 3. Adrenocorticotrophic Hormone 4. Length Of Stay 5. Organ dysfunction 6. Intensive Care 7. Mechanical ventilation
outcomes:
Iron therapy in anaemic adults without chronic kidney disease
1. All Cause Mortality 2. Serious Adverse Event 3. Blood Transfusion 4. Quality of Life 5. Duration Of Hospital Stay 6. Hemoglobin concentration
outcomes:
Isotonic versus hypotonic solutions for maintenance intravenous fluid administration in children
1. Overhydration 2. Hyponatremia 3. Death 4. Cerebral Edema 5. Seizure
outcomes:
Exercise for reducing fear of falling in older people living in the community
1. Falls 2. Fear-related avoidance of activities 3. Fear Of Falling 4. Physical Activity Level 5. Depressive symptoms 6. Anxiety
outcomes:
Salicylate‐containing rubefacients for acute and chronic musculoskeletal pain in adults
1. Pain On Movement Of Skeletal Muscle 2. Pain Onset At Rest 3. Pain 4. Pain Scale 5. Treatment Success 6. Pain On Joint Movement 7. Pain Relief 8. Patient's Global Evaluation 9. Clinical Improvement 10. Patient-Reported Outcome
outcomes:
Intravenous lidocaine for the treatment of background or procedural burn pain
1. Analgesia 2. Visual Analog Scale 3. Verbal Rating Scale 4. Rescue Medication 5. Pain Intensity
outcomes:
Advanced trauma life support training for hospital staff
1. Death
outcomes:
Oral or parenteral iron supplementation to reduce deferral, iron deficiency and/or anaemia in blood donors
1. Ferritin level 2. Blood Donor Deferral 3. Hemoglobin concentration
outcomes:
Steroidal contraceptives: effect on bone fractures in women
1. Bone Density 2. Fracture 3. Bone turnover rate
outcomes:
Femoral nerve blocks for acute postoperative pain after knee replacement surgery
1. Serious Adverse Event 2. Pain 3. Nausea And Vomiting 4. Opioids 5. Axonotmesis 6. Range Of Knee Flexion 7. Patient Satisfaction
outcomes:
Single dose oral etoricoxib for acute postoperative pain in adults
1. Serious Adverse Event 2. Death 3. Adverse Event 4. Pain Relief
outcomes:
Interventions for treating fingertip entrapment injuries in children
1. Finding Of Nail Growth 2. Growth Delay 3. Hypertrophic Scar 4. Functional ability 5. Nail Deformity 6. Necrosis 7. Wound Infection 8. Nail growth abnormal
outcomes:
Hip protectors for preventing hip fractures in older people
1. Falls 2. Hip Fracture 3. Skin Irritation 4. Fracture 5. Pelvic Fracture
outcomes:
Selective computed tomography (CT) versus routine thoracoabdominal CT for high‐energy blunt‐trauma patients
1. Death
outcomes:
The Lund concept for severe traumatic brain injury
1. Death
outcomes:
Hyperbaric oxygen therapy for treating acute surgical and traumatic wounds
1. Wound Healing 2. Adverse Event
outcomes:
Single dose oral dexibuprofen [S(+)‐ibuprofen] for acute postoperative pain in adults
1. Pain 2. Serious Adverse Event 3. Adverse Event 4. Rescue Medication 5. Pain Relief 6. Patient's Global Evaluation 7. Patient-Reported Outcome
outcomes:
Primary closure versus delayed closure for non bite traumatic wounds within 24 hours post injury
1. Wound Healing 2. Wound Infection
outcomes:
Single dose oral celecoxib for acute postoperative pain in adults
1. Time-to-Event 2. Pain Relief
outcomes:
Antibiotics for treating chronic osteomyelitis in adults
1. Infection 2. Infection Of Bone 3. Remission of infection
outcomes:
Antipsychotics for acute and chronic pain in adults
1. Pain Intensity
outcomes:
Opioids compared to placebo or other treatments for chronic low‐back pain
1. Disability 2. Oswestry Disability Index 3. Pain 4. Pain Scale 5. Disability Rating Scale 6. Nausea 7. Roland-Morris Disability Questionnaire 8. Constipation 9. Sleepiness 10. Pain Relief 11. Pain Intensity
outcomes:
Electrotherapy for neck pain
1. Disability 2. Pain 3. Work-related disability 4. Quality of Life 5. Adverse Event 6. Pain Relief 7. Patient's Global Evaluation 8. Patient Satisfaction 9. Pain Intensity
outcomes:
Single dose oral tenoxicam for acute postoperative pain in adults
1. Withdrawn From Research Study 2. Serious Adverse Event 3. Pain 4. Withdrawal Due To Adverse Events 5. Adverse Event 6. Rescue Medication 7. Time-to-Event 8. Pain Relief 9. Patient's Global Evaluation 10. Patient Status 11. Pain Intensity 12. Patient-Reported Outcome
outcomes:
Physical activity and education about physical activity for chronic musculoskeletal pain in children and adolescents
1. Disability 2. Adverse Event 3. Pain Intensity
outcomes:
Automated mandatory bolus versus basal infusion for maintenance of epidural analgesia in labour
1. Cesarean Section 2. Delivery Procedure 3. Pain
outcomes:
Physiotherapy for pain and disability in adults with complex regional pain syndrome (CRPS) types I and II
1. Disability 2. Adverse Event 3. Pain Intensity
outcomes:
Implanted spinal neuromodulation interventions for chronic pain in adults
1. Adverse Event 2. Pain Intensity
outcomes:
Single‐dose intravenous ibuprofen for acute postoperative pain in adults
1. Serious Adverse Event 2. Adverse Event 3. Rescue Medication 4. Time-to-Event 5. Pain Relief
outcomes:
Single‐dose intravenous ketorolac for acute postoperative pain in adults
1. Serious Adverse Event 2. Adverse Event 3. Rescue Medication 4. Time-to-Event 5. Pain Relief
outcomes:
Non‐steroidal anti‐inflammatory drugs (NSAIDs) for trigger finger
1. Range Of Motion Activity 2. Trigger finger 3. Treatment Success 4. Severe Pain 5. Adverse Event 6. Patient-Reported Outcome
outcomes:
Relief of pain due to uterine cramping/involution after birth
1. Analgesia 2. Pain 3. Health Services Utilization 4. Breastfeeding Painful 5. Duration Of Hospital Stay 6. Readmission 7. Interactions 8. Breastfeeding At Discharge From Hospital 9. Adverse Event 10. Patient Satisfaction
outcomes:
Psychological therapies for the management of chronic pain (excluding headache) in adults
1. Disability 2. Distress 3. Adverse Event 4. Pain Intensity
outcomes:
Topical anaesthesia plus intracameral lidocaine versus topical anaesthesia alone for phacoemulsification cataract surgery in adults
1. Postoperative Pain 2. Adverse Anesthesia Outcome 3. Anaesthesia Insufficient 4. Intraoperative Pain 5. Drug toxicity 6. Patient Satisfaction
outcomes:
Early enteral nutrition (within 48 hours) versus delayed enteral nutrition (after 48 hours) with or without supplemental parenteral nutrition in critically ill adults
1. Pneumonia 2. All Cause Mortality 3. Weaning From Mechanically Assisted Ventilation 4. Feeding intolerance 5. Length Of Stay 6. Infection As Complication Of Medical Care 7. Gastrointestinal Complication
outcomes:
Adductor canal blocks for postoperative pain treatment in adults undergoing knee surgery
1. Postoperative Pain 2. Postoperative Nausea 3. Fall
outcomes:
Bispectral index for improving intraoperative awareness and early postoperative recovery in adults
1. Awareness During Anaesthesia 2. Time to eye opening 3. Time to discharge
outcomes:
Perioperative intravenous ketamine for acute postoperative pain in adults
1. Central Nervous System Diagnostic Radiopharmaceuticals 2. Vomiting 3. Patient Controlled Analgesia 4. Opioids 5. Nausea 6. Pain Relief 7. Pain Intensity 8. Hyperalgesia
outcomes:
Pre‐emptive and preventive opioids for postoperative pain in adults undergoing all types of surgery
1. Postoperative Pain 2. Bradycardia 3. Morphine 4. Low Blood Pressure 5. Decreased Respiratory Function
outcomes:
Adverse side effects of dexamethasone in surgical patients
1. Glycaemia Control 2. Wound Healing Delayed 3. Postoperative Wound Infection
outcomes:
Maternal position in the second stage of labour for women with epidural anaesthesia
1. Cesarean Section 2. Abnormal Fetal Heart Rate 3. Maternal Blood Loss Heavy 4. Finding Of Duration Of Labor 5. Instrumental Delivery 6. Second stage of labor 7. Umbilical Cord Finding 8. Vaginal Delivery 9. Intensive Care 10. Repair Of Perineal Tear
outcomes:
Single‐dose intravenous diclofenac for acute postoperative pain in adults
1. Serious Adverse Event 2. Adverse Event 3. Rescue Medication 4. Pain Relief
outcomes:
Intravenous versus inhalational maintenance of anaesthesia for postoperative cognitive outcomes in elderly people undergoing non‐cardiac surgery
1. Delirium 2. Cognitive impairment
outcomes:
Mirtazapine for fibromyalgia in adults
1. Serious Adverse Event 2. Sleep Problem 3. Withdrawal Due To Adverse Events 4. Weight Gain 5. Patient Global Impression of Improvement 6. Sleepiness 7. Pain Relief 8. Patient-Reported Outcome
outcomes:
Enteral versus parenteral nutrition and enteral versus a combination of enteral and parenteral nutrition for adults in the intensive care unit
1. Pneumonia 2. All Cause Mortality 3. Ventilator Finding 4. Aspiration 5. Vomiting 6. Sepsis 7. Duration Of Hospital Stay 8. Intensive Care
outcomes:
Melatonin for the promotion of sleep in adults in the intensive care unit
1. Difficulty Sleeping 2. Length of ICU Stay 3. Sleep Finding 4. Death 5. Depression 6. Anxiety 7. Adverse Event
outcomes:
Cannabis‐based medicines for chronic neuropathic pain in adults
1. Serious Adverse Event 2. Mental disorder 3. Withdrawal Due To Adverse Events 4. Patient Global Impression of Improvement 5. Pain Relief 6. Nervous system disorder
outcomes:
Alpha‐2 adrenergic agonists for the prevention of cardiac complications among adults undergoing surgery
1. All Cause Mortality
outcomes:
Use of hyaluronidase as an adjunct to local anaesthetic eye blocks to reduce intraoperative pain in adults
1. Intraoperative Pain
outcomes:
Cerebral near‐infrared spectroscopy (NIRS) for perioperative monitoring of brain oxygenation in children and adults
1. Delirium 2. Stroke
outcomes:
Propofol for the promotion of sleep in adults in the intensive care unit
1. Difficulty Sleeping 2. Sleep Finding 3. Depression 4. Anxiety 5. Adverse Event
outcomes:
Oxcarbazepine for neuropathic pain
1. Pain Sensation Reduced 2. Pain 3. Serious Adverse Event
outcomes:
Cuffed versus uncuffed endotracheal tubes for general anaesthesia in children aged eight years and under
1. Stridor
outcomes:
Dexamethasone as an adjuvant to peripheral nerve block
1. Postoperative Pain 2. Serious Adverse Event 3. Duration of Block 4. Peripheral Block Anesthesia 5. Visual Analog Scale
outcomes:
Nerve blocks or no nerve blocks for pain control after elective hip replacement (arthroplasty) surgery in adults
1. Postoperative Complication 2. Pain 3. Patient-Reported Outcome